Press Release: European Medicines Agency recommends conditional approval of Pixuvri (pixantrone) for relapsed or refractory aggressive non-Hodgkin’s B-cell lymphoma

Author (Corporate)
Series Title
Series Details EMA/CHMP/121961/2012 (17.2.12)
Publication Date 17/02/2012
Content Type
Source Link Link to Main Source http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/02/news_detail_001448.jsp&mid=WC0b01ac058004d5c1&murl=menus/news_and_events/news_and_events.jsp&jsenabled=true
Related Links
EMA: Press Release: EMA/CHMP/121961/2012 (17.2.12): cEuropean Medicines Agency recommends conditional approval of Pixuvri (pixantrone) for relapsed or refractory aggressive non-Hodgkin’s B-cell lymphoma http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2012/02/WC500122943.pdf

Subject Categories
Countries / Regions